These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 33706324)

  • 1. Clinicopathological Features, Prognostic Factors, Survival Trends, and Treatment of Malignant Ovarian Germ Cell Tumors: A SEER Database Analysis.
    Guo H; Chen H; Wang W; Chen L
    Oncol Res Treat; 2021; 44(4):145-153. PubMed ID: 33706324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical management of malignant ovarian germ cell tumors: A 26-year experience in a tertiary care institution.
    Hu T; Fang Y; Sun Q; Zhao H; Ma D; Zhu T; Wang C
    Surg Oncol; 2019 Dec; 31():8-13. PubMed ID: 31446304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical analysis of 15 cases of malignant ovarian germ cell tumors with lung metastasis].
    Liu Y; Ren T; Feng FZ; Wan XR; Shen K; Xiang Y
    Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):40-4. PubMed ID: 22455692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors and clinic-pathologic characteristics of ovarian tumor with different histologic subtypes-a SEER database population study of 41,376 cases.
    Shao C; Guo H; Chen L; Chen J; Wang L; Wang H
    Transl Cancer Res; 2023 Aug; 12(8):1937-1950. PubMed ID: 37701106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG network.
    Derquin F; Floquet A; Hardy-Bessard AC; Edeline J; Lotz JP; Alexandre J; Pautier P; Angeles MA; Delanoy N; Lefeuvre-Plesse C; Cancel M; Treilleux I; Augereau P; Lavoue V; Kalbacher E; Berton Rigaud D; Selle F; Nadeau C; Gantzer J; Joly F; Guillemet C; Pomel C; Favier L; Abdeddaim C; Venat-Bouvet L; Provansal M; Fabbro M; Kaminsky MC; Lortholary A; Lecuru F; Coquard IR; de La Motte Rouge T
    Gynecol Oncol; 2020 Sep; 158(3):666-672. PubMed ID: 32624235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The individualized significance of lymphadenectomy across all age groups and histologies in malignant ovarian germ cell tumors.
    Wang J; Chen R; Li J; Lu X
    Arch Gynecol Obstet; 2020 Dec; 302(6):1441-1450. PubMed ID: 32888090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological Features and Survival Trends of Non-Epithelial Ovarian Cancer: Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database.
    Zhang C; Xi X
    Oncol Res Treat; 2023; 46(11):476-492. PubMed ID: 37857263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is Omentectomy Mandatory Among Early Stage (I, II) Malignant Ovarian Germ Cell Tumor Patients? A Retrospective Study of 223 Cases.
    Xu W; Li Y
    Int J Gynecol Cancer; 2017 Sep; 27(7):1373-1378. PubMed ID: 28520571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Malignant ovarian germ cell tumors--clinical characteristics and analysis of outcomes].
    Miedzińska-Maciejewska M; Bobkiewicz P; Gawrychowski K
    Ginekol Pol; 2011 May; 82(5):338-43. PubMed ID: 21851031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant ovarian germ cell tumor - role of surgical staging and gonadal dysgenesis.
    Lin KY; Bryant S; Miller DS; Kehoe SM; Richardson DL; Lea JS
    Gynecol Oncol; 2014 Jul; 134(1):84-9. PubMed ID: 24836278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of Surgery Alone and Surveillance Strategy in Young Women With Stage I Malignant Ovarian Germ Cell Tumors.
    Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Int J Gynecol Cancer; 2016 Jun; 26(5):859-64. PubMed ID: 27101582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Features and Survival Outcomes in Children and Adolescents With Malignant Mediastinal Germ Cell Tumors Based on Surveillance, Epidemiology, and End Results Database Analysis.
    Wu P; Yang Y; Yu Z; Zhao L; Feng S
    J Surg Res; 2023 Aug; 288():362-371. PubMed ID: 37062232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic factors in malignant ovarian germ cell tumours (The Surveillance, Epidemiology and End Results experience 1978-2010).
    Solheim O; Gershenson DM; Tropé CG; Rokkones E; Sun CC; Weedon-Fekjaer H; Fosså SD
    Eur J Cancer; 2014 Jul; 50(11):1942-50. PubMed ID: 24857045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic factors analysis in patients with ovarian malignant germ cell tumor treated with fertility-preserving surgery].
    Yang ZJ; Wei RJ; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):898-904. PubMed ID: 23324188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fertility-preserving surgery for advanced stage ovarian germ cell tumors.
    Nasioudis D; Frey MK; Chapman-Davis E; Caputo TA; Holcomb K
    Gynecol Oncol; 2017 Dec; 147(3):493-496. PubMed ID: 29021083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of staging and adjuvant chemotherapy in stage I malignant ovarian germ cell tumors (MOGTs): the MITO-9 study.
    Mangili G; Sigismondi C; Lorusso D; Cormio G; Candiani M; Scarfone G; Mascilini F; Gadducci A; Mosconi AM; Scollo P; Cassani C; Pignata S; Ferrandina G
    Ann Oncol; 2017 Feb; 28(2):333-338. PubMed ID: 27803008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance Only for High-risk FIGO Stage IA/IB Malignant Ovarian Germ Cell Tumors: Results From a National Cancer Database.
    Nasioudis D; Frey MK; Chapman-Davis E; Caputo TA; Holcomb KM
    Am J Clin Oncol; 2021 May; 44(5):195-199. PubMed ID: 33710136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant ovarian germ cell tumors: presentation, survival and second cancer in a population based Norwegian cohort (1953-2009).
    Solheim O; Kærn J; Tropé CG; Rokkones E; Dahl AA; Nesland JM; Fosså SD
    Gynecol Oncol; 2013 Nov; 131(2):330-5. PubMed ID: 24001518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of lymph node staging method and prognostic factors in malignant ovarian sex cord-stromal tumors: A world wide database analysis.
    Wang J; Li J; Chen R; Lu X
    Eur J Surg Oncol; 2018 Jul; 44(7):1054-1061. PubMed ID: 29705285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoreductive surgery in advanced stage malignant ovarian germ cell tumors.
    Karalok A; Comert GK; Kilic C; Turkmen O; Kilic F; Basaran D; Boyraz G; Tekin ÖM; Turan T
    J Gynecol Obstet Hum Reprod; 2019 Sep; 48(7):461-466. PubMed ID: 31228608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.